Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -3.9 Million CAD | 57.28% |
| 2023 | -9.19 Million CAD | 6.15% |
| 2022 | -9.79 Million CAD | -1065.53% |
| 2021 | -840.3 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -3.92 Million CAD | 57.28% |
| 2024 Q4 | -842.4 Thousand CAD | -24.81% |
| 2024 Q3 | -674.93 Thousand CAD | 53.86% |
| 2024 Q2 | -1.46 Million CAD | 25.01% |
| 2024 Q1 | -1.95 Million CAD | 17.13% |
| 2023 FY | -9.19 Million CAD | 6.15% |
| 2023 Q3 | -1.88 Million CAD | 18.44% |
| 2023 Q4 | -2.35 Million CAD | -25.05% |
| 2023 Q2 | -2.3 Million CAD | 12.79% |
| 2023 Q1 | -2.64 Million CAD | 33.1% |
| 2022 Q3 | -2.9 Million CAD | -66.42% |
| 2022 Q2 | -1.74 Million CAD | -46.08% |
| 2022 Q1 | -1.19 Million CAD | -87.04% |
| 2022 FY | -9.79 Million CAD | -1065.53% |
| 2022 Q4 | -3.95 Million CAD | -36.37% |
| 2021 FY | -840.3 Thousand CAD | 0.0% |
| 2021 Q4 | -638 Thousand CAD | -326.74% |
| 2021 Q2 | -52.79 Thousand CAD | 0.0% |
| 2021 Q3 | -149.5 Thousand CAD | -183.21% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 94.556% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 179.519% |
| SQZ Biotechnologies Company | -75.82 Million USD | 94.846% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 78.102% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 104.775% |
| Mesoblast Limited | -84.14 Million USD | 95.356% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -154.432% |
| Genus plc | 6.4 Million USD | 161.066% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 140.115% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -319.614% |
| Marizyme, Inc. | -34.08 Million USD | 88.534% |
| ContraFect Corporation | -56.88 Million USD | 93.13% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 53.195% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 14.195% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -178.76% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -37.105% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -42.073% |
| MultiCell Technologies, Inc. | -722.81 USD | -540594.927% |
| Accustem Sciences Inc. | -3.74 Million USD | -4.318% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 93.375% |
| EV Biologics, Inc. | -483.06 Thousand USD | -709.047% |
| Q BioMed Inc. | -3.44 Million USD | -13.425% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 210.401% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -903.208% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -48.741% |
| Biomind Labs Inc. | -1 Million USD | -287.102% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 19.907% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 41.213% |
| Skye Bioscience, Inc. | -13.67 Million USD | 71.414% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -96.74% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -12948.2% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 22.525% |
| IMV Inc. | -38.67 Million USD | 89.894% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 75.373% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -102.224% |
| GB Sciences, Inc. | -1.42 Million USD | -175.127% |
| Alpha Cognition Inc. | -9.7 Million USD | 59.733% |
| HST Global, Inc. | -140.9 Thousand USD | -2673.6% |
| CSL Limited | 3.7 Billion USD | 100.106% |
| Halberd Corporation | -75.05 Thousand USD | -5107.458% |
| Enzolytics Inc. | -2.14 Million USD | -81.878% |
| Resverlogix Corp. | -12.74 Million USD | 69.345% |
| Affymax, Inc. | -15.04 Million USD | 74.025% |
| SYBLEU INC | -149.18 Thousand USD | -2519.786% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -23.354% |
| argenx SE | -425.04 Million USD | 99.081% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 92.959% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -274.348% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -147.455% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -14.779% |
| AVAX Technologies, Inc. | 6.69 Million USD | 158.393% |
| Zenith Capital Corp. | -8.94 Million USD | 56.299% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.06% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -22333.827% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -59.173% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -2178.705% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 92.891% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -34.707% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -297.153% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -109.626% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -211.162% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -94.946% |
| BioStem Technologies, Inc. | -7.77 Million USD | 49.759% |
| ONE Bio Corp. | 13.68 Million USD | 128.565% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -2053.455% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -192.654% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -247.424% |
| Agentix Corp. | -1.37 Million USD | -184.905% |
| LadRx Corporation | -3.82 Million USD | -2.212% |
| Cell Source, Inc. | -4.32 Million USD | 9.644% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -840.649% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -468.92% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -468.92% |
| NovAccess Global Inc. | -2.46 Million USD | -58.434% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -33.868% |
| Itoco Inc. | -919.14 Thousand USD | -325.201% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 7.791% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -249.258% |
| Kadimastem Ltd | -3.04 Million USD | -28.549% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1393.24% |
| CytoDyn Inc. | -18.05 Million USD | 78.358% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -15427.203% |
| Mobile Lads Corp. | -554.55 Thousand USD | -604.751% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1675.824% |
| Qrons Inc. | -643.67 Thousand USD | -507.167% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -592.056% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -75.265% |
| Rebus Holdings, Inc. | -664 Thousand USD | -488.584% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -115.171% |
| International Stem Cell Corporation | -663 Thousand USD | -489.472% |
| Bioxytran, Inc. | -3.82 Million USD | -2.305% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -7324.386% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -19114.341% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 89.224% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -141.545% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -431.124% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -25.625% |
| Neutra Corp. | -229.48 Thousand USD | -1603.022% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 77.717% |
| PureTech Health plc | -146.19 Million USD | 97.327% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 81.815% |
| IXICO plc | -1.43 Million USD | -171.969% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 58.822% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 96.791% |
| CSL Limited | 3.81 Billion USD | 100.103% |
| Cellectis S.A. | -108.85 Million USD | 96.41% |